Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eleveld PK Model for Propofol and Remifentanil in Cardiac Anesthesia with CPB
2023-507808-31-00Phase 4Authorised
- Sponsor
- Medical University of Vienna
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Recofol N and remifentanil in Cardiac valve disease (VHD), coronary arteriosclerosis and aortopathy, sponsored by Medical University of Vienna. Planned start Apr 2024; status: authorised.
02
Drugs
Recofol Nremifentanil
03
Conditions
Cardiac valve disease (VHD)coronary arteriosclerosisaortopathy
Beyond the preview
Go deeper on 2023-507808-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507808-31-00.